Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: St. Jude

This article was originally published in The Gray Sheet

Executive Summary

St. Jude: Receives FDA approval of its new Woodridge pyrolytic carbon component production facility in Little Canada, Minnesota. The facility has the capacity to manufacture the pyrolytic carbon components for all St. Jude mechanical heart valve products , and the company will gradually increase production over the next several years. Under the terms of a 1990 supply agreement with Carbomedics, St. Jude can manufacture up to 50% of its pyrolytic carbon valve components in 1995 and up to 80% thereafter until the Carbomedics deal terminates in 1998....
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004503

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel